The COPD Assessment Test (CAT) can screen for fatigue among patients with COPD

Therapeutic Advances in Respiratory Disease

Volumn 12, Issue , 2018, Pages

  Stridsman, Caroline ^a   Svensson, My ^b   Johansson Strandkvist, Viktor ^a   Hedman, Linnea ^a,b   Backman, Helena ^b   Lindberg, Anne ^b  

^a LULEÅ UNIVERSITY OF TECHNOLOGY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

anxiety; chronic obstructive pulmonary disease; fatigue; health related quality of life; respiratory symptoms

Indexed keywords

AGED; ANXIETY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EXAMINATION; CLINICAL STUDY; CONTROLLED STUDY; COPD ASSESSMENT TEST; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; FUNCTIONAL STATUS ASSESSMENT; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE ASSESSMENT; SPIROMETRY; VISUAL ANALOG SCALE; EVALUATION STUDY; FORCED EXPIRATORY VOLUME; HEALTH STATUS; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANXIETY; DEPRESSION; FATIGUE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMANS; LUNG; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 85054592561     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753466618787380     Document Type: Article

References (32)

1. Adeloye D, Chua S, Lee C. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health 2015; 5: 020415
2. Backman H, Eriksson B, Rönmark E. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med 2016; 114: 103–110
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD 2017, http://goldcopd.org (2017, accessed October 2017)
4. Stridsman C, Muellerova H, Skär L. Fatigue in COPD and the impact of respiratory symptoms and heart disease: a population-based study. COPD 2013; 10: 125–132
5. Christensen VL, Holm AM, Cooper B. Differences in symptom burden among patients with moderate, severe, or very severe chronic obstructive pulmonary disease. J Pain Symptom Manage 2016; 51: 849–859
6. Kentson M, Todt K, Skargren E. Factors associated with experience of fatigue, and functional limitations due to fatigue in patients with stable COPD. Ther Adv Respir Dis 2016; 10: 410–424
7. Stridsman C, Skär L, Hedman L. Fatigue affects health status and predicts mortality among subjects with COPD: report from the population-based OLIN COPD study. COPD 2015; 12: 199–206
8. Pickard AS, Wilke C, Jung E. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med 2008; 102: 519–536
9. Karloh M, Fleig Mayer A, Maurici R. The COPD assessment test: what do we know so far? A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest 2016; 149: 413–425
10. Zanini A, Aiello M, Adamo D. Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care 2015; 60: 88–95
11. Andersson M, Stridsman C, Rönmark E. Physical activity and fatigue in chronic obstructive pulmonary disease: a population based study. Respir Med 2015; 109: 1048–1057
12. Paddison JS, Effing TW, Quinn S. Fatigue in COPD: association with functional status and hospitalisations. Eur Respir J 2013; 41: 565–570
13. Stridsman C, Lindberg A, Skär L., Fatigue in chronic obstructive pulmonary disease: a qualitative study of people’s experiences. Scand J Caring Sci 2014; 28; 130–138
14. Spruit M, Vercoulen J, Sprangers M. Fatigue in COPD: an important yet ignored symptom. Lancet Respir Med 2017; 5: 542–544
15. McCarthy B, Casey D, Devance D. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2: CD003793
16. Jones PW, Harding G, Berry P. Development and first validation of the COPD assessment test. Eur Respir J 2009; 34: 648–654
17. Lindberg A, Bjerg A, Rönmark E. Prevalence and underdiagnosis of COPD by disease severity and attributable fraction of smoking. Report from the Obstructive Lung Disease in Northern Sweden studies. Respir Med 2006; 100: 264–272
18. Miravitlles M, Soriano JB, Garcia-Rio F., Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863–868
19. Lindberg A, Lundbäck B., The Obstructive Lung Disease in Northern Sweden chronic obstructive pulmonary disease study: design, the first year, participation and mortality. Clin Respir J 2008; 2: 64–71
20. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152: 1107–1136
21. Backman H, Lindberg A, Oden A. Reference values for spirometry: report from the Obstructive Lung Disease in Northern Sweden studies. Eur Clin Respir J 2015; 2: 26375
22. Mahler DA, Wells CK., Evaluation of clinical methods for rating dyspnea. Chest 1988; 93: 580–586
23. Al-shair K, Kolsum U, Dockry R. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res 2011; 12: 3
24. Baghai-Ravary R, Quint J, Goldring J. Determinants and impact of fatigue in patients with chronic obstructive pulmonary disease. Respir Med 2009; 103: 216–223
25. Al-shair K, Muellerova H, Yorke J. Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes 2012; 10: 100
26. Cella D., Manual of the functional assessment of chronic illness therapy (FACIT) measurement system. Evanston, IL: Center on Outcomes, Research and Education (Core), Evanston Northwestern Healthcare and Northwestern University, 1997
27. Jones PW, Brusselle G, Dal Negro RW. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J 2011; 38: 29–35
28. Han MK, Muellerova H, Curran-Everett D. Implications of the GOLD 2011 disease severity classification in the COPDGene cohort. Lancet Respir Med 2013; 1: 43–50
29. Akgun Sahin Z, Dayapoglu N. Effect of progressive relaxation exercises on fatigue and sleep quality in patients with chronic Obstructive Lung Disease (COPD). Complement Ther Clin Pract 2015; 21: 277–281
30. Deng GJ, Liu FR, Zhong QL. The effect of non-pharmacological staged interventions on fatigue and dyspnoea in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Int J Nurs Pract 2013; 19: 636–643
31. Qvist L, Nilsson U, Johansson V. Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study. Eur Clin Respir J 2015; 2: 10.3402
32. Srivastava K, Thakur D, Sharma S. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics 2015; 33: 467–488